Back to Search Start Over

A recombinant multiepitope protein for hepatitis B diagnosis.

Authors :
de Souza MQ
Galdino AS
dos Santos JC
Soares MV
de Nóbrega YC
Alvares Ada C
de Freitas SM
Torres FA
Felipe MS
Source :
BioMed research international [Biomed Res Int] 2013; Vol. 2013, pp. 148317. Date of Electronic Publication: 2013 Nov 05.
Publication Year :
2013

Abstract

Hepatitis B is a liver inflammation caused by hepatitis B virus (HBV) and can be diagnosed in clinical stage by hepatitis B core antibody from IgM class (anti-HBcIgM). Hepatitis B core antibody from IgG class (Anti-HBcIgG) appears quickly after IgM, reaching high titers in chronic hepatitis, and remains even after cure. Since hepatitis B core antibody (anti-HBc) is the first antibody identified and sometimes the only marker detected during the course of infection, it can be used both to indicate HBV acute infection (anti-HBc-IgM) and to identify individuals who have come into contact with the virus (anti-HBc-IgG). In this work we propose a recombinant hepatitis B core multiepitope antigen (rMEHB) to be used for diagnosis of hepatitis B. For this purpose, a synthetic gene coding for rMEHB was designed and cloned into vector pET21a with a 6xHis tag at the C-terminal. Time course induction in E. coli showed an induced protein with an apparent molecular mass of ~21 kDa. Protein purification was performed by a single step with affinity chromatography Ni-NTA. Circular dichroism spectroscopy indicated rMEHB as a thermal stable protein at pH 7.0 and 8.0. In these conditions rMEHB was successfully used to perform an enzyme linked immuno sorbent assay (ELISA) with positive and negative sera.

Details

Language :
English
ISSN :
2314-6141
Volume :
2013
Database :
MEDLINE
Journal :
BioMed research international
Publication Type :
Academic Journal
Accession number :
24294596
Full Text :
https://doi.org/10.1155/2013/148317